Drug Development Drug Efficacy Research Studies Phase 3 Trials Cancer Research Animal Studies Randomized Controlled Trials Cancer Treatment Research Methodology Phase 1 Trials Efficacy Studies Preclinical Research Patient Care Phase 2 Trials Patient Outcomes Drug Approval Phase III Trials FDA Approval Gene Therapy Preclinical Studies Phase I Trials Experimental Treatments Vaccine Trials Human Studies Drug Trials Patient Studies Human Trials Animal Testing Pharmaceuticals Translational Medicine Study Design Vaccine Development Weight Loss Oncology Human Health Phase II Trials Phase 3 Studies Cancer Treatments Patient Safety Randomized Trials Medical Research Gene Therapy Trials Vaccine Efficacy Regulatory Approval Weight Loss Medications Therapeutics Innovative Therapies Medical Treatments Transplantation Animal Models Therapeutic Applications Weight Management Regulatory Affairs Immunotherapy Participant Studies Drug Research Drug Testing Phase Studies Innovative Treatments Weight Loss Studies Therapeutic Development Preclinical Testing Neuroscience Obesity Research Participants Heart Disease Cancer Treatment Trials Therapies Biopharmaceuticals Effectiveness Pharmacology Medical Devices Investigational Drugs Evidence-Based Medicine Research and Development Mid-Stage Trials Phase Trials Phase One Trials Therapeutic Research Preclinical Models Drug Safety Treatment Efficacy Therapeutic Innovations Experimental Drugs Safety and Efficacy Phase I/II Trials Human Testing Brain Signals Research Diversity Pharmaceutical Research Alzheimer's Disease Drug Medical Regulators Genetic Counseling Animal Research Phase 2 Studies Stem Cell Therapy Phase 3 Clinical Trial Pilot Studies Placebo Treatments Epilepsy Research
The company says less-frequent injections could improve patient persistence versus weekly drugs.
